Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers [Phase 1]
Phase 1 study of AB598 as monotherapy and in combination across multiple advanced cancers is ongoing, with status active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Outcomes of Definitive Radiotherapy for Bladder Cancer
A clinical trial (NCT07503795) led by Sohag University is investigating outcomes of definitive radiotherapy for bladder cancer; the study is…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial [NA]
This clinical trial update outlines a non-inferiority randomized study evaluating whether performing a urine bacterial culture before transu…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial [Phase 1, Phase 2]
The INVITE trial is investigating in-home intravesical chemotherapy for non-muscle invasive bladder cancer and is currently recruiting for P…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue [NA]
A Memorial Sloan Kettering Cancer Center trial evaluating radiation therapy for solid tumors that have metastasized to soft tissue. The stud…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Early vs Delayed Intravesical Blad-Care During BCG Therapy [NA]
A recruiting clinical trial evaluating early versus delayed intravesical Blad-Care during BCG therapy for bladder cancer and BCG-induced cys…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2)
Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2) from Imperial College London indicates the study is currently recruiting for mu…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors [NA]
A Rutgers-sponsored clinical trial aims to improve coordination between cancer care teams and primary care for complex cancer survivors. The…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)
A bladder cancer clinical study evaluating energy metabolism using resting indirect calorimetry, currently recruiting at University of Kansa…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2, Phase 3]
A Phase 2/3 clinical trial update evaluating datopotamab deruxtecan plus platinum chemotherapy versus gemcitabine plus platinum in locally a…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Bio Clinical Collection of Urothelial Carcinoma
This clinical trial update describes the Bio Clinical Collection of Urothelial Carcinoma trial, sponsored by University Hospital, Toulouse, …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630 [Phase 1]
A Phase I 'window of opportunity' study of UGN-201 in bladder cancer patients undergoing radical cystectomy is being conducted, with the tri…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer [Phase 3]
Phase 3 trial update assessing intravesical TARA-002 versus investigator's choice intravesical chemotherapy for BCG-naïve high-grade non-mus…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy [NA]
A clinical trial comparing mannitol versus nitroglycerin to prevent acute kidney injury during robotic-assisted radical prostatectomy or cys…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder Cancer
Feasibility study evaluating urinary cell-free DNA as a non-invasive monitoring tool in prostate cancer and bladder cancer.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Bladder Bank (a Prospective Banking Study)
This is a status update for a prospective bladder cancer biobanking study (Bladder Bank) sponsored by Mayo Clinic, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.
A feasibility study sponsored by Origin Sciences is recruiting to investigate rectal mucus in aero-digestive tract cancers, including Non-Sm…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer [Phase 1]
Phase 1 clinical trial evaluating IO102-IO103 in combination with pembrolizumab for high-risk non-muscle invasive bladder cancer that is unr…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Study of NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder Cancer [Phase 3]
Relmada Therapeutics is evaluating NDV-01, a sustained-release gemcitabine-docetaxel formulation, in Phase 3 for non-muscle invasive bladder…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer [Phase 2]
This document provides a status update on a Phase 2 trial evaluating intravesical gemcitabine and docetaxel for low-grade, intermediate-risk…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
The University of Kansas Medical Center is conducting a longitudinal biorepository for bladder cancer to support development of novel therap…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: The Effects of the 4-7-8 Breathing Technique on Sleep Quality, Pain, and Recovery Outcomes in Patients Undergoing Transurethral Resection of the Bladder [NA]
The trial investigates the effects of the 4-7-8 breathing technique on sleep quality, pain, and recovery after transurethral resection of th…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery [EARLY_Phase 1]
This early-phase trial update describes the combination of durvalumab and tremelimumab in cisplatin-ineligible muscle-invasive urothelial ca…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Telehealth Intervention for Ostomy Self-Management [Phase 2]
Phase 2 clinical trial update for a telehealth intervention to support ostomy self-management. The study includes patients with colorectal c…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers [Phase 2]
Clinical trial update on a Phase 2 study of ado-trastuzumab emtansine for HER2-amplified or HER2-mutant cancers; the trial is currently acti…